Learn about the ATMP-HE regulatory pathway to accellerate patient access and gain clinical data
Oct 2025
What could Most Favoured Nation pricing mean for CGT launches
What is MFN pricing, how might it be calculated (via International Reference Pricing) and what impact might it have globally, particularly for CGT products
July 2025
Challenges in Technology Transfer of Cell Therapies
An overview of the cross-border tech transfer challenges specific to cell therapy manufacturing processes
June 2025
The Global Cell and Gene Therapy Pipeline: Current Landscape and Funding Outlook
A health-check review of the CGT pipeline compared with all modalities in conjunction with a YoY deal value assessment by source
Download the file: